Article
Antifolates and MTHFR.
Therapeutic drug monitoring - 1 Dec 2015
Trachtman Joseph N, Pagano Vincent
Abstract excerpt
We describe a patient who developed symptoms of headache, fatigue, and dizziness after administration of terbinafine (Lamisil). Laboratory tests revealed that he is heterozygous for the C677T variation of the methylenetetrahydrofolate reductase genetic mutation. The prescription of Deplin (L-methylfolate) greatly reduced the symptoms. It was later noted that Lamisil's mechanism of action interferes with cells'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
